General Anesthesia. 2010

Embed Size (px)

Citation preview

  • 7/31/2019 General Anesthesia. 2010

    1/32

    General Anesthesia

  • 7/31/2019 General Anesthesia. 2010

    2/32

  • 7/31/2019 General Anesthesia. 2010

    3/32

    Definition:

    A reversible state of analgesia, amnesia, loss of consciousness, inhibitionof sensory and autonomic reflexes and variable degrees of skeletal

    muscle relaxation.

    Mechanism of action

    the general anesthetics increase the sensitivity of the (GABAA) receptorsto the neurotransmitter, GABA.

    Binding of GABA causes the chloride Ion channel to open, leading to

    hyperpolarization of the cell.

    Postsynaptic neuronal excitability is thus diminished.

    the activity of the inhibitory glycine receptors in the spinal motor neurons

    is increased.

    block excitatory postsynaptic current of the nicotinic receptors.

  • 7/31/2019 General Anesthesia. 2010

    4/32

  • 7/31/2019 General Anesthesia. 2010

    5/32

  • 7/31/2019 General Anesthesia. 2010

    6/32

  • 7/31/2019 General Anesthesia. 2010

    7/32

  • 7/31/2019 General Anesthesia. 2010

    8/32

    INDUCTION, MAINTENANCE, AND RECOVERY FROM ANESTHESIA

    InductionAim: During induction, it is essential to avoid the dangerous excitatory phase

    (Stage II delirium).

    Induction occurs with an intravenous anesthetic like thiopental, which

    produces unconsciousness within 25 seconds after injection.

    Maintenance of anesthesiaDef. Maintenance is the period during which the patient is surgically

    anesthetized.

    Anesthesia is usually maintained by the administration of volatile

    anesthetics, because these agents offer good minute-tominute control over

    the depth of anesthesia.

    Recovery Posoperatively, the anesthesiologist withdraws the anesthetic mixture and

    monitors the return of the patient to consciousness.

  • 7/31/2019 General Anesthesia. 2010

    9/32

  • 7/31/2019 General Anesthesia. 2010

    10/32

    INHALATION ANESTHETICS

    Inhaled gases are used primarily for the maintenance of anesthesia

    after administration of an intravenous agent.

    A. Common features of inhaled anesthestics

    Inhalation anesthetics are nonflammable, nonexplosive agents.

    These agents decrease cerebrovascular resistance, resulting in

    increased perfusion of the brain.

    They also cause bronchodilation.

  • 7/31/2019 General Anesthesia. 2010

    11/32

    Potency

    MAC is the concentration of anesthetic gas needed to eliminate

    movement among 50% percent of patients exposed to a noxious

    stimulus.

    MAC is small for potent anesthetics, such as halothane, and large for

    less potent agents, as nitrous oxide.

    Therefore, the inverse of MAC is an index of potency of the

    anesthetic.

  • 7/31/2019 General Anesthesia. 2010

    12/32

  • 7/31/2019 General Anesthesia. 2010

    13/32

  • 7/31/2019 General Anesthesia. 2010

    14/32

    a. Solubility in the blood: (blood/gas partition coefficient).

    An anesthetic gas with low blood solubility (nitrous oxide), diffuses

    from the alveoli into the circulation, little of the anesthetic dissolvesin theblood. Therefore, the equilibrium between the inhaled

    anesthetic and arterial blood occurs rapidly.

    An anesthetic gas with high blood solubility (halothane), dissolves

    more completely in the blood and greater amounts of the anesthetic

    and longer periods time are required to raise arterial partial

    pressure. This results in increased times of induction as well as

    recovery.

    The solubility blood is ranked in the following order: halothane >

    enflurane> isoflurane > sevoflurane > desflurane > nitrous oxide.

  • 7/31/2019 General Anesthesia. 2010

    15/32

  • 7/31/2019 General Anesthesia. 2010

    16/32

  • 7/31/2019 General Anesthesia. 2010

    17/32

    3. Effect of different tissue types on anesthetic uptake:

    The time required to achieve a steady-state is inversely

    proportional to the blood flow to that tissue; e.g. faster flow results

    in a more rapidly achieved steady-state.

    The time required to achieve a steady-state is directly proportional

    to the capacity of that tissue, a larger capacity results in a longer

    time required to achieve steady-state.A- Brain, heart, liver, kidney, and endocrine glands:highly

    perfused tissues rapidly attain a steady-state with the partial

    pressure of anesthetic in the blood.

    B- Skeletal muscles:poorly perfused tissuesprolong the timerequired to achieve steady-state.

    C- Fat:poorly perfused tissues and has a large capacity so prolong

    time to achieve steady state.

    d-Bone, ligaments, and cartilage:These are poorly perfused and

    have a relatively low capacity to store anesthetic.

  • 7/31/2019 General Anesthesia. 2010

    18/32

  • 7/31/2019 General Anesthesia. 2010

    19/32

    Halothane

    Therapeutic uses:

    halothane is a potent anesthetic, it is a relatively weak analgesic.

    Halothane relaxes both skeletal and uterine muscle.

    Halothane is not hepatotoxic in pediatric patients, and, combinedwith its pleasant odor, this makes it suitable in children for inhalation

    induction.

    Safe for asthmatics

    Pharmacokinetics:

    Halothaneis metabolized to tissue-toxic hydrocarbons (for example,

    trifluroethanol and bromide ion.

    50% of patients will die of hepatic necrosis. not repeated at intervals less

    than two to three weeks.

  • 7/31/2019 General Anesthesia. 2010

    20/32

    Adverse effects:1. Hepatitis

    2. Cardiac effects:

    halothaneis vagomimetic and causes bradycardia.

    halothanecauses cardiac arrhythmias due to increase in the plasma

    concentration of catecholamines.

    Halothane, produces concentration-dependent hypotension.

    3. Malignant hyperthermia:

    all of the halogenated hydrocarbon anesthetics as well as the

    muscle relaxant succinylcholine

    have the potential to inducemalignant hyperthermia. (Genetic defect in muscle calcium)

    a dramatic increase in the myoplasmic calcium concentration.

    Treated by dantrolene.

  • 7/31/2019 General Anesthesia. 2010

    21/32

    F. Enflurane less potent than halothane, but produces rapid induction and

    recovery.

    About 2% of the anesthetic is metabolized to fluoride ion,

    which is excreted by the kidney. Therefore, enfluraneis

    contraindicated in patients with kidney failure.

    Advantages:

    Enfluraneanesthesia exhibits the following differences fromhalothane:

    fewer arrhythmias.

    less sensitization of the heart to catecholamines.

    greater potentiation of muscle relaxants due more potent

    "curare-like" effect.

    disadvantage:

    Nephrotoxic (fluoride ion). central nervous system (CNS) excitation at twice the MAC For

    this reason, it is not used in patients with seizure disorders.

  • 7/31/2019 General Anesthesia. 2010

    22/32

    Isofurane It is very stable molecule that undergoes little metabolism; as a result,

    little fluoride is produced.

    Advantages:1. isofluraneis not tissue toxic.

    2. isoflurane does not induce cardiac arrhythmias and does not sensitize

    the heart the action of catecholamines.

    3. Adequate muscle relaxation.

    Disadvantages:1. It produces concentrationdependent hypotension due to peripheral

    vasodilation.

    2. All halogenated inhalation anesthetics have been reported to cause

    hepatitis, but at a much lower incidence than with halothane.3. Irritant on bronchi

  • 7/31/2019 General Anesthesia. 2010

    23/32

    Sevoflurane

    Advantages:

    Sevoflurane has low pungency, allowing rapid uptakewithout irritating the airway during induction, thus making it

    able for induction in children.

    The drug has low solubility in blood, and is rapidly takenand excreted.

    Recovery is faster than with other anesthetics.

    Disadvantages:

    It is metabolized by the liver, releasing fluoride ions; thus,

    like enflurane, may prove to be nephrotoxic.

  • 7/31/2019 General Anesthesia. 2010

    24/32

    Nitrous oxide

    Nitrous oxideis a potent analgesic but a weak general anesthetic.

    Nitrous oxide is poorly soluble in blood and other tissues, allowing

    it move very rapidly in and out of the body.

    nitrous oxide isused at concentrations of 30% in combination with oxygen

    for analgesia, particularly in dental surgery.

    nitrous oxide at 80% (without adjunct agents) cannot produce

    surgical anesthesia. It is combined with other, more potent agents to attain pain-free

    anesthesia.

    Advantages:

    it has moderate to no effect on the cardiovascular systemDisadvantages:

    diffusion hypoxia.

    This anesthetic doesnot produce muscle relaxation

  • 7/31/2019 General Anesthesia. 2010

    25/32

  • 7/31/2019 General Anesthesia. 2010

    26/32

    V. INTRAVENOUS ANESTHETICS

    Barbiturates

    Thiopental: is a potent but a weak analgesic. It is an ultra-short acting barbiturate and has a high lipid solubility.

    1. Rapid and pleasant induction, Rapid recovery.

    Benzodiazepines (Medazolam)

    Opioids:

    the combination ofmorphine and nitrous oxide provides good anesthesia for

    cardiac surgery.

    The most frequently employed opioids arefentanyl and, sufentanil,because

    they induce analgesia more rapidly than does morphine.

  • 7/31/2019 General Anesthesia. 2010

    27/32

    Etomidate:

    Advantages: little to no effect on the heart and circulation.

    It is only used for coronary artery disease or cardiovascularDisadvantages:

    a decrease in plasma cortisol and aldosterone levels.

    produce more involuntary movements during induction.

    to cause postoperative nausea and vomiting

    Ketamine: (Dissociative anesthesia)

  • 7/31/2019 General Anesthesia. 2010

    28/32

    Ketamine: (Dissociative anesthesia)

    a short-acting, nonbarbiturate anesthetic.

    Dissociated state in which the patient is unconscious but appears to be

    awake and does not feel pain.

    The drug is lipophilic and enters the brain very quickly, itredistributes to other organs and tissues.

    It is metabolized in the liver, but small excreted unchanged.

    Mechanism of action:interact with -N-methyl-D-aspartate receptor

    Advantages:

    1. provides sedation, amnesia, and immobility.

    2. Profound analgesia

    3. Cardiovascular stimulation through central sympathetic stimulation(increase blood pressure, heart rate and cardiac output).

    4. No respiratory depression.

    5. No laryngospasm.

    Contraindicated in hypertensive or stroke patients.

  • 7/31/2019 General Anesthesia. 2010

    29/32

    Disadvantages:

    1. it increases cerebral blood flow2. induces postoperative hallucinations ("nightmares"),

    particularly in adult

    3. Unpleasant dreams.

  • 7/31/2019 General Anesthesia. 2010

    30/32

    Propofol

    Propofol is an intravenous sedative/hypnotic used in the induction or

    maintenance of anesthesia.

    Onset is smooth, occurs within about 40 seconds of administration.

    Supplementation with narcotics for analgesia is required.

    Disadvantages:

    1. propofolfaclitates depression in the CNS, it is occasionally accompaniedby excitatory phenomena, such as muscle twitching, spontaneous

    movement, or hiccups.

    2. Propofoldecreases blood pressure without depressing the myocardium.

    Advantages:

    1. It is the first choice for anesthesia induction and sedation.

    2. it produces euphoric feeling in the patient

    3. does not cause postanesthetic nausea and vomiting.

    4. It reduces intracranial pressure.5. T his makes propofolvery useful for such surgeries as resection of

    spinal tumors.

  • 7/31/2019 General Anesthesia. 2010

    31/32

    Neuroleptanesthesia: (Inovar)

    It is a state of sedation, reduced motor activity, analgesia and

    amnesia but without loss of consciousness.

    the combined use of neuroleptic droperidol with a powerful

    opioid fentanyl and nitrous oxide with oxygen.

  • 7/31/2019 General Anesthesia. 2010

    32/32